Portfolio (Quarterly)
Guide ↗
BRAIDWELL LP
· CIK 0001920938| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | RGEN | REPLIGEN CORP | Healthcare | 81,790.0 | $13.4M | 0.43% | -114K | -58.2% | $163.86 | -36.4% |
| 62 | ICLR | ICON PLC | Healthcare | 73,370.0 | $13.4M | 0.43% | NEW | — | $182.22 | -37.6% |
| 63 | — | KINIKSA PHARMACEUTICALS INTL | — | 313,823.0 | $12.9M | 0.41% | -329K | -51.2% | $41.25 | — |
| 64 | GRAL | GRAIL INC | Healthcare | 142,755.0 | $12.2M | 0.39% | NEW | — | $85.59 | -29.1% |
| 65 | — | SURROZEN INC | — | 470,000.0 | $10.6M | 0.34% | +330K | +235.7% | $22.60 | — |
| 66 | RLMD | RELMADA THERAPEUTICS INC | Healthcare | 1,582,257.0 | $7.6M | 0.24% | NEW | — | $4.83 | +31.3% |
| 67 | XNCR | XENCOR INC | Healthcare | 459,166.0 | $7.0M | 0.23% | -787K | -63.2% | $15.31 | -27.8% |
| 68 | CSTL | CASTLE BIOSCIENCES INC | Healthcare | 177,183.0 | $6.9M | 0.22% | -646K | -78.5% | $38.90 | -50.3% |
| 69 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 311,991.0 | $5.1M | 0.16% | -424K | -57.6% | $16.24 | -21.7% |
| 70 | BLLN | BILLIONTOONE INC | Healthcare | 50,000.0 | $4.1M | 0.13% | NEW | — | $81.84 | +5.2% |
| 71 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 84,795.0 | $2.6M | 0.08% | -1.3M | -93.9% | $30.31 | +92.5% |
| 72 | KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | 303,370.0 | $2.2M | 0.07% | NEW | — | $7.36 | +1.1% |
| 73 | LUNG | PULMONX CORP | Healthcare | 752,541.0 | $1.7M | 0.05% | — | — | $2.21 | -41.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%